{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase III, Randomized, Open-Label, Multi-Center, Global Study of Volrustomig (MEDI5752) as Sequential Therapy Versus Observation in Participants with Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma, Who Have Not Progressed Following Definitive Concurrent Chemoradiotherapy.","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-iii-randomized-open-label-multi-center-global-study-of-volrustomig-medi5752-as-sequential-therapy-versus-observation-in-participants-with-unresected-locally-advanced-head-and-neck-squamo\/#breadcrumbitem"}]}